Literature DB >> 22258558

A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.

Misaki Hirose1, Tomoya Nishino, Tadashi Uramatsu, Yoko Obata, Mineaki Kitamura, Tayo Kawazu, Masanobu Miyazaki, Takashi Taguchi, Shigeru Kohno.   

Abstract

A 50-year-old woman with a 1-month history of lower extremity edema and a 5 kg weight increase was admitted to our hospital with suspected nephrotic syndrome in October 1999. Urine protein level was 3.5 g per day, 10-15 erythrocytes in urine per high-power field, and serum albumin level 2.5 g/dl. Furthermore, an accumulation of pleural effusion was confirmed by chest X-ray. The results of a renal biopsy indicated slight mesangial proliferation in the glomeruli by light microscopy, and an immunofluorescence study confirmed the deposition of immunoglobulin (Ig) A and C3 in the mesangial area. Diffuse attenuation of foot processes and dense deposits in the mesangial area were observed by electron microscopy. Treatment with 40 mg/day of prednisolone was effective, and proteinuria was negative 1 month later. Because of this course, we diagnosed minimal change nephrotic syndrome complicated by mild-proliferative IgA nephropathy. In November 2000, there was a relapse of nephrotic syndrome, which was believed to be induced by an influenza vaccination, but response to increased steroid treatment was favorable, and proteinuria disappeared on day 13 of steroid increase. A second relapse in May 2001, showed steroid resistance with renal insufficiency, and an increase in the selectivity index to 0.195. Light microscopy revealed focal sclerotic lesions of the glomeruli, and an immunofluorescence study revealed attenuation of mesangial IgA and C3 deposition. These findings led to the diagnosis that minimal change nephrotic syndrome had transitioned to focal segmental glomerulosclerosis, whereby mesangial IgA deposition was reduced by immunosuppressive treatment. Subsequently, her renal function gradually worsened to the point of end-stage renal failure by 27 months after the second relapse of nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258558     DOI: 10.1007/s10157-011-0580-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  20 in total

1.  Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?

Authors:  N Yoshikawa; H Ito
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

2.  Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis.

Authors:  P Sinnassamy; S O'Regan
Journal:  Am J Kidney Dis       Date:  1985-05       Impact factor: 8.860

3.  Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.

Authors:  Khalil El Karoui; Gary S Hill; Alexandre Karras; Luc Moulonguet; Valérie Caudwell; Alexandre Loupy; Patrick Bruneval; Christian Jacquot; Dominique Nochy
Journal:  Kidney Int       Date:  2010-12-22       Impact factor: 10.612

4.  Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.

Authors:  R J Glasser; J A Velosa; A F Michael
Journal:  Lab Invest       Date:  1977-05       Impact factor: 5.662

5.  An overlapping syndrome of IgA nephropathy and lipoid nephrosis.

Authors:  K N Lai; F M Lai; K W Chan; C P Ho; A C Leung; J Vallance-Owen
Journal:  Am J Clin Pathol       Date:  1986-12       Impact factor: 2.493

6.  The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy.

Authors:  J Mustonen; A Pasternack; I Rantala
Journal:  Clin Nephrol       Date:  1983-10       Impact factor: 0.975

7.  Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Observation of two cases.

Authors:  G Barbiano di Belgiojoso; G Mazzucco; S Casanova; L Radaelli; G Monga; L Minetti
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

8.  [Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].

Authors:  Misao Tsukada; Kazuho Honda; Kosaku Nitta; Wako Yumura; Hiroshi Nihei
Journal:  Nihon Jinzo Gakkai Shi       Date:  2003-10

9.  Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis.

Authors:  N Yanai-Berar; O Ben-Itzhak; J Gree; F Nakhoul
Journal:  Clin Nephrol       Date:  2002-09       Impact factor: 0.975

10.  Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?

Authors:  T H Westhoff; R Waldherr; C Loddenkemper; W Ries; W Zidek; M van der Giet
Journal:  Clin Nephrol       Date:  2006-03       Impact factor: 0.975

View more
  2 in total

1.  IgA nephropathy with minimal change disease.

Authors:  Leal C Herlitz; Andrew S Bomback; Michael B Stokes; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

2.  Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy.

Authors:  Keisuke Suzuki; Naoto Miura; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2013-09-20       Impact factor: 2.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.